太陽能(000591.SZ):2個光伏電站項目列入福建省2024年度光伏電站開發建設方案項目清單
格隆匯11月4日丨太陽能(000591.SZ)公佈,近日,福建省發展和改革委員會發布《關於印發福建省2024年度光伏電站開發建設方案的通知》(閩發改新能〔2024〕502號),公司下屬子公司申報的中節能詔安四都150MW漁光互補光伏電站、中節能太陽能城廂靈川70MW漁光互補光伏電站成功列入福建省2024年度光伏電站開發建設方案項目清單。
以上2個光伏電站項目列入福建省2024年度光伏電站開發建設方案項目清單,有利於公司緊抓雙碳戰略機遇,深化福建省內光伏發電業務佈局,提升公司新能源裝機規模,其發電收入將為公司提供持久穩定的收入及現金流。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.